Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Risk Strategy Requirement Change For Low Platelet Counts Drugs, Nplate And Promacta -
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2664125" data-attributes="member: 124445"><p>The FDA approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for both Nplate (romiplostim) and Promacta (eltrombopag). According to an FDA-initiated review of the current information, Nplate and Promacta still pose certain safety risks, but certain restrictive requirements of the REMS programs are no longer required to ensure that the drugs' benefits outweigh their risks. The FDA (Food and Drug Administration, USA) will continue to monitor both medications for safety risks...<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/puNui9S94XU" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/puNui9S94XU/238896.php" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2664125, member: 124445"] The FDA approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for both Nplate (romiplostim) and Promacta (eltrombopag). According to an FDA-initiated review of the current information, Nplate and Promacta still pose certain safety risks, but certain restrictive requirements of the REMS programs are no longer required to ensure that the drugs' benefits outweigh their risks. The FDA (Food and Drug Administration, USA) will continue to monitor both medications for safety risks...[IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/puNui9S94XU[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/puNui9S94XU/238896.php]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top